NCT01023698

Brief Summary

Is it possible to do a panretinal photocoagulation for proliferative diabetic retinopathy in a single session using low fluence parameters?

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2009

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2009

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 2, 2009

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

November 26, 2009

Last Update Submit

May 29, 2024

Conditions

Keywords

Diabetic retinopathyDiabetic macular edemaPanretinal photocoagulation

Outcome Measures

Primary Outcomes (1)

  • Stabilization of proliferative diabetic retinopathy

    2010

Study Arms (1)

photocoagulation

EXPERIMENTAL

Laser photocoagulation

Procedure: laser photocoagulation

Interventions

Laser photocoagulation

photocoagulation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • untreated Proliferative diabetic retinopathy

You may not qualify if:

  • Previous photocoagulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetic Retinopathy

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Study Officials

  • Maria A Martinez-Castellanos, MD

    Asociacion para Evitar la Ceguera en México

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2009

First Posted

December 2, 2009

Study Start

April 1, 2009

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

May 30, 2024

Record last verified: 2024-05